Breast cancer
Novel small molecule blocks breast and ovarian cancer in mice
A groundbreaking discovery in the fight against breast and ovarian cancers has emerged from the laboratories of Baylor College of ...
Keytruda’s Success in KEYNOTE-756 Trial Ushers in a New Era for Early-Stage High-Risk ER+/HER2â Breast Cancer Treatment (ESMO 2023)
ESMO 2023: LBA21 Keytruda (pembrolizumab) is a highly specific, human-made antibody that targets the PD-1 pathway and prevents cancer cells ...
Hologic Partners with Nonprofit for ‘Know Your Lemons’ Breast Cancer Education Drive
In observance of Breast Cancer Awareness Month, Hologic is intensifying its efforts to promote breast health. The Massachusetts-based company, known ...
Galderma Initiates Breast Cancer Campaign Focusing on Aesthetic Solutions for Survivor Confidence
In observance of Breast Cancer Awareness Month this October, Galderma, a specialist in dermatology, has partnered with the National Breast ...
EstĂ©e Lauderâs Pink Ribbon Campaign for Breast Cancer
With a historic legacy of three decades of unwavering dedication to breast cancer awareness, the Estée Lauder Companies are set ...
NICE rejects Enhertu for HER2-low breast cancer over cost concerns
The remarkable efficacy data that initially earned AstraZeneca and Daiichi Sankyo’s Enhertu a standing ovation at the ASCO meeting last ...
AstraZeneca and Daiichi Reach Key Milestone in Breast Cancer ADC Trial, Paving Way to Challenge Gilead
AstraZeneca and Daiichi Sankyo are making a strategic move to challenge Gilead Sciences’ position in the breast cancer arena. They ...
FDA approves worldâs first MRI-compatible breast biopsy robot
Insight Medbotics has achieved FDA clearance for what it claims to be the world’s first surgical robot designed to operate ...
Ibex raises $55M to expand its AI-powered cancer diagnostics in the US and beyond
Ibex Medical Analytics, an Israeli startup specializing in Artificial intelligence-powered cancer diagnostics, has secured an impressive $55 million in funding ...
BioNTech and DualityBio Advance Novel HER2-low Breast Cancer Drug to Phase III Trial
BioNTech, the renowned name behind the COVID-19 vaccine breakthrough, is venturing into uncharted territory with its licensed antibody-drug conjugate (ADC), ...
Tecentriq SC: A Swift Leap Forward in Cancer Treatment Receives Green Light
Roche has proudly unveiled that Tecentriq SC (atezolizumab) has received the stamp of approval from the Medicines and Healthcare products ...
Seagen’s Tukysa Demonstrates Trial Victory in Breast Cancer, Amplifying Roche’s Kadcyla and Significance in Light of Pfizer’s $43B Acquisition
In a strategic move, Pfizer has announced a hefty investment of $43 billion to acquire Seagen, with a keen focus ...
Trodelvy: The New Hope for Breast Cancer Patients
Trodelvy is a brand name for sacituzumab govitecan-hziy, a new type of drug that combines an antibody with a chemotherapy ...
CHMP Greenlights Elacestrant for Advanced Breast Cancer Treatment in the EU
Source – Menarini Group A new treatment option for postmenopausal women with advanced or metastatic breast cancer has moved a ...
Enhertu Receives Approval in China as Groundbreaking HER2-Directed Therapy for HER2-Low Metastatic Breast Cancer Patients
Source – AstraZeneca Enhertu (trastuzumab deruxtecan), a targeted antibody drug conjugate developed by AstraZeneca and Daiichi Sankyo, has received approval ...
In the US, patients with advanced HR-positive breast cancer are given priority review for the combination of capivasertib and Faslodex
Source- Astrazeneca The US Food and Drug Administration (FDA) has accepted and granted Priority Review to AstraZeneca’s New Drug Application ...
Roche’s HER2 Powerhouse: Leading the Way in Breast Cancer Treatment
Breast cancer treatment was primarily based on the tumor’s location for most of the previous century, resulting in varying outcomes. ...
